Electroretinogram Market Size
Electroretinogram Market Analysis
The Electroretinogram Market size is estimated at USD 61.78 million in 2025, and is expected to reach USD 92.90 million by 2030, at a CAGR of 8.5% during the forecast period (2025-2030).
The studied market is driven by several factors such as increasing cases of eye disorders in developed countries, the rising prevalence of glaucoma among individuals, and the growing geriatric population worldwide during the forecast period.
The high prevalence of retinal diseases and emerging complications associated with the retina enhance the demand for Electroretinograms (ERG) for proper diagnosis. Diseases such as diabetes-related retinopathy, retinal detachment, retinal tears or holes, retinal vein occlusion, birdshot chorioretinopathy, and other inflammatory diseases are mostly identified with the help of an electroretinogram. An increase in the diabetic population is a significant driver of market expansion since diabetes causes various ophthalmic issues, including diabetes-related retinopathy. As per the 2022 report from the International Diabetic Federation (IDF), the total number of people living with diabetes is anticipated to rise to 643 million by 2030 and 783 million by 2045. Thus, as the diabetic population is more prone to suffering from various eye diseases, the market is likely to grow over the forecast period due to the increased demand for electroretinograms.
Furthermore, various research studies have been conducted across the globe discussing the advantages of electroretinograms for retinal disease diagnosis. For instance, as per the article published in January 2024 in Frontiers in Cellular Neuroscience, researchers showed that the variables extracted from the resting activity of the retina evaluated by electroretinograms (ERG) enabled the predictive diagnosis of risk factors for type 2 diabetes among patients. Similarly, as per the article published in October 2023 in the Diagnostics journal, the researchers showed that ERG remains relevant for quantitatively assessing retinal cells in vivo. Thus, owing to the rise in benefits offered by the ERG in diagnosing retinal diseases, the studied market is expected to witness notable growth over the forecast period.
Thus, owing to the increase in cases of retinal diseases and rise in benefits offered by the ERG in diagnosis, the studied market is expected to grow significantly over the forecast period. However, high cost of electroretinography is likely to restrain the market growth over the forecast period.
Electroretinogram Market Trends
Portable Electroretinograms is Expected to Hold a Major Market Share Over the Forecast Period
The portable electroretinogram is a handheld, lightweight, and easy-to-use instrument that can objectively measure retinal function. It is particularly useful for assessing patients in nursing homes who may have difficulty with traditional ERG testing.
The portable electroretinogram segment is expected to witness notable growth owing to its ease of use, benefits, and advantages in retinal disease diagnoses.
There are various advantages offered by the portable ERG, such as no direct contact with the eye being required, ease of use without pupil dilation, and offering diagnostic information similar to standard ERG systems, etc. Further, an increase in research articles establishing the importance of portable electroretinograms in diagnosing retinal diseases is expected to drive segment growth over the forecast period. For instance, as per the article published in April 2023 in the Documenta Ophthalmologica journal, the utilization of a portable RETeval unit was found to be beneficial in recording highly reproducible and diagnostically useful clinical ERGs. Thus, such advances make them more acceptable among the population, leading to segment growth over the forecast period.
Furthermore, as per the article published in April 2024 in the Clinical Monthly Bulletins for Ophthalmology, researchers showed that as patients are reluctant to place corneal or conjunctival electrodes, the utilization of portable ERG devices is usually adopted. Hence, such patient preferences are expected to drive the segment growth over the forecast period.
North America is Expected to Witness a Significant Growth Over the Forecast Period
North America is expected to witness notable growth in the studied market owing to the increase in diabetic retinopathy, the rise in expenditure on eye disease diagnosis, and the increase in awareness programs for early disease detection and strategic activities by key players in the country.
The geriatric population is more susceptible to retinal diseases, which compels patients to undergo early diagnosis and increases the adoption of ERG. Furthermore, the high prevalence of diabetes cases accentuates the cases of diabetic retinopathy, which ultimately leads to the utilization of ERG. For instance, according to the May 2023 update by the Canadian Association of Optometrists, 3.7 million people are living with diabetes in Canada, whereas the number of Canadians living with diabetes is estimated to rise to 4.9 million in 2030. Hence, the increasing prevalence of diabetes is likely to drive the electroretinogram market significantly in the forecast period.
Furthermore, an increase in awareness campaigns conducted across the region is expected to drive the segment growth over the forecast period. For instance, in September 2023, Prevent Blindness conducted its third annual Inflammatory Eye Disease (IED) Awareness Week, whereas the awareness educated people on the importance of early diagnosis of the various types of IEDs.
Hence, owing to the rise in the prevalence of diabetic retinopathy cases, an increase in awareness activities will fuel market growth and is anticipated to further propel the growth of the electroretinogram market in the region.
Electroretinogram Industry Overview
The electroretinogram market is semi-consolidated in nature and consists of several major players. A few of the major players are currently dominating the market in terms of market share. Some of the companies that are currently present in the market are Electro-Diagnostic Imaging Inc, Roland-consult, CSO Italia, Metrovision , Diagnosys LLC, LKC Technologies, LumiThera, Evoq Technologies LLC, Neurosoft, and Konan Medical USA Inc.
Electroretinogram Market Leaders
-
CSO Italia
-
Metrovision
-
LKC Technologies
-
Neurosoft
-
Konan Medical USA Inc
- *Disclaimer: Major Players sorted in no particular order
Electroretinogram Market News
- October 2023: the International Agency for the Prevention of Blindness (IAPB) observed ‘World Sight Day’, focusing on helping people understand the importance of protecting their vision in the workplace and notifying business leaders to prioritize the eye health of workers.
- June 2023: Neusoft installed their 100th Neuro-ERG system in South Korea. Neuro-ERG utilizes clinical electrophysiologic testing of vision, which is intended for objective assessment of visual pathways starting from the retina to the cortex.
Electroretinogram Industry Segmentation
As per the scope of the report, electroretinogram (ERG) is a reliable, non-invasive test that assesses the electrical response of retinal cells to light stimuli. It can be employed to diagnose various eye diseases such as glaucoma and diabetic retinopathy.
The Electroretinogram Market is segmented by Type, Application and Geography. By type, the market is segmented into fixed electroretinogram and portable electroretinogram. By application, the market is segmented into research and developments, and clinical uses. By geography the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for the above segments.
By Type | Fixed Electroretinogram | ||
Portable Electroretinogram | |||
By Application | Research and Developments | ||
Clinical Use | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle-East and Africa | GCC | ||
South Africa | |||
Rest of Middle-East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Fixed Electroretinogram |
Portable Electroretinogram |
Research and Developments |
Clinical Use |
North America | United States |
Canada | |
Mexico | |
Europe | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe | |
Asia-Pacific | China |
Japan | |
India | |
Australia | |
South Korea | |
Rest of Asia-Pacific | |
Middle-East and Africa | GCC |
South Africa | |
Rest of Middle-East and Africa | |
South America | Brazil |
Argentina | |
Rest of South America |
Electroretinogram Market Research FAQs
How big is the Electroretinogram Market?
The Electroretinogram Market size is expected to reach USD 61.78 million in 2025 and grow at a CAGR of 8.5% to reach USD 92.90 million by 2030.
What is the current Electroretinogram Market size?
In 2025, the Electroretinogram Market size is expected to reach USD 61.78 million.
Who are the key players in Electroretinogram Market?
CSO Italia, Metrovision, LKC Technologies, Neurosoft and Konan Medical USA Inc are the major companies operating in the Electroretinogram Market.
Which is the fastest growing region in Electroretinogram Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Electroretinogram Market?
In 2025, the North America accounts for the largest market share in Electroretinogram Market.
What years does this Electroretinogram Market cover, and what was the market size in 2024?
In 2024, the Electroretinogram Market size was estimated at USD 56.53 million. The report covers the Electroretinogram Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Electroretinogram Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.